- Home
- PMTS vs PRQR Comparison
PMTS vs PRQR Comparison
Compare PMTS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- PRQR
- Stock Information
- Founded
- PMTS 2007
- PRQR 2012
- Country
- PMTS United States
- PRQR Netherlands
- Employees
- PMTS N/A
- PRQR N/A
- Industry
- PMTS Finance Companies
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- PMTS Finance
- PRQR Health Care
- Exchange
- PMTS Nasdaq
- PRQR Nasdaq
- Market Cap
- PMTS 316.9M
- PRQR 309.5M
- IPO Year
- PMTS 2015
- PRQR 2014
- Fundamental
- Price
- PMTS $28.62
- PRQR $1.69
- Analyst Decision
- PMTS Strong Buy
- PRQR Strong Buy
- Analyst Count
- PMTS 5
- PRQR 6
- Target Price
- PMTS $34.40
- PRQR $8.50
- AVG Volume (30 Days)
- PMTS 35.4K
- PRQR 406.6K
- Earning Date
- PMTS 03-04-2025
- PRQR 03-13-2025
- Dividend Yield
- PMTS N/A
- PRQR N/A
- EPS Growth
- PMTS N/A
- PRQR N/A
- EPS
- PMTS 1.64
- PRQR N/A
- Revenue
- PMTS $480,601,000.00
- PRQR $20,235,014.00
- Revenue This Year
- PMTS $8.62
- PRQR $39.44
- Revenue Next Year
- PMTS $7.15
- PRQR N/A
- P/E Ratio
- PMTS $17.45
- PRQR N/A
- Revenue Growth
- PMTS 8.11
- PRQR 105.20
- 52 Week Low
- PMTS $15.21
- PRQR $1.61
- 52 Week High
- PMTS $35.19
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- PMTS 44.09
- PRQR 27.75
- Support Level
- PMTS $27.15
- PRQR $1.78
- Resistance Level
- PMTS $31.85
- PRQR $1.87
- Average True Range (ATR)
- PMTS 1.99
- PRQR 0.15
- MACD
- PMTS -0.31
- PRQR -0.05
- Stochastic Oscillator
- PMTS 20.69
- PRQR 0.00
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.